Włodarczyk et al. demonstrated that the GLUT5 inhibitor MSNBA effectively inhibits colon cancer cell proliferation with negligible effects on normal cells, reinforcing that GLUT5-mediated fructose utilization preferentially supports cancer cell proliferation 133. Here, SLC2A5 is linked to cancer.